| Title |
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial
|
|---|---|
| Published in |
Trials, October 2020
|
| DOI | 10.1186/s13063-020-04819-9 |
| Pubmed ID | |
| Authors |
Ashkan Emadi, Joel V. Chua, Rohit Talwani, Søren M. Bentzen, John Baddley |
X Demographics
The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4 | 40% |
| Nigeria | 1 | 10% |
| Unknown | 5 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 6 | 60% |
| Scientists | 4 | 40% |
Mendeley readers
The data shown below were compiled from readership statistics for 518 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 518 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 82 | 16% |
| Researcher | 42 | 8% |
| Student > Master | 42 | 8% |
| Other | 33 | 6% |
| Student > Doctoral Student | 22 | 4% |
| Other | 77 | 15% |
| Unknown | 220 | 42% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 114 | 22% |
| Nursing and Health Professions | 46 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 40 | 8% |
| Biochemistry, Genetics and Molecular Biology | 14 | 3% |
| Psychology | 9 | 2% |
| Other | 53 | 10% |
| Unknown | 242 | 47% |